Navigation Links
SIRO Clinpharm Forms Alliance with Korean CRO DreamCIS
Date:2/9/2010

MUMBAI, India, Feb. 9 /PRNewswire/ -- SIRO Clinpharm, a Contract Research Organization (CRO) with a presence in India, Western and Central Eastern Europe, and the United States today announced its alliance with DreamCIS Inc., a leading CRO based in Seoul, South Korea.  

DreamCIS has nearly a decade of experience in offering clinical research services to pharmaceutical companies, bio venture companies, medical device manufacturers, and functional food producers. Their services includes Clinical Trial Management, Pharmacovigilance, Post Marketing Surveillance (PMS), Data Management, Biostatistics and Quality Assurance services.

SIRO Clinpharm has been in the arena of contract clinical research for more than 14 years, conducting ICH GCP compliant clinical trials for its global clientele. In addition to the services that DreamCIS provides, SIRO's service list also includes Medical Writing, Clinical Trials Supplies Management, Feasibility and Patient Planning.

"This pact will help us on one hand to build a strong competitive advantage in the Asia Pacific region, while on the other hand it will create a sustainable value for our existing as well as potential customers," said Ajit Nair, Ph.D., President, India. He further added that, "Our goal is to offer a wider platform of patient recruitment capabilities from the Asia Pac region for our global client base."

"We are one of the leading and fastest growing CROs in South Korea. However, looking at the increasing number of global clinical trials and the rapid growth in the Asian clinical trials market, we were looking at associating ourselves with a CRO having a global exposure; not only from business vertical perspective but also from the perspective of moving up on the learning curve. I think our mutually beneficial alliance with SIRO is a definite step in this direction," said Won-Jung Choi, President, DreamCIS Inc.    

"Korea is a rapidly growing clinical trials market due to various advantages it offers like pre-approved and well-equipped clinical trial sites, trained professionals, and transparent and efficient regulatory processes," said Chetan Tamhankar, PhD, SIRO's Chief Executive Officer. "We are confident this alliance will be of immense value to SIRO and widen our global service capabilities."

About SIRO:

SIRO Clinpharm Private Limited (SIRO) is among one of the leading global Clinical Research Organizations (CROs), offering full scope services, conducting clinical trials in the pharmaceutical, biotechnology and medical devices sectors in compliance with international standards. SIRO is one of the first CROs founded in India, which caters to the needs of pharmaceutical companies across the world. The company has offices in India, the USA, Israel and in Europe in Germany, Romania, Estonia, Greece, Czech Republic and Spain.

For more information please visit - www.siroclinpharm.com

About DreamCIS:

Founded in April, 2000, DreamCIS has been dedicated to providing a full range of clinical services for pharmaceutical companies, bio venture companies medical device manufacturers and functional food producers in Korea. The company has also undertaken projects for some of the top global pharmaceutical companies in a broad range of therapeutic areas in accordance with ICH GCP guidelines.

For more information please visit – www.dreamcis.com

SOURCE SIRO Clinpharm

RELATED LINKS
http://www.siroclinpharm.com

'/>"/>

SOURCE SIRO Clinpharm
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. SIRO Clinpharm Collaborates with Mediscis, Broadens Early Phase Drug Development Expertise
2. DBMS Consulting Successfully Completes Roll out of Oracle Health Sciences Applications (OHSA) Suite for SIRO Clinpharm
3. SIRO Clinpharm and CambReg Ltd Strategic Alliance to Offer Regulatory Services in Europe
4. SIRO Clinpharm Completes Successful Implementation of Oracle Life Sciences Application Suite
5. VisEn Acquires Key Fluorescence Agent Intellectual Property Portfolio and Technology Platforms From Bayer Schering Pharma
6. JDRF Forms Partnership With Animas to Develop First-Generation Automated System for Managing Type 1 Diabetes
7. Zassi Medical Evolutions Spins out Electrical Stimulation Technology for Gastrointestinal Continence Control and Forms New Company with Technology Investment Firm
8. Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group
9. Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines
10. Rules-Based Medicine Forms Biomarker Alliance With Covance Inc.
11. CareFusion Launches Knowledge Portal to Provide Actionable Information Across Product Platforms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas ... Brasil as the company,s second affiliate in Latin America . ... ... of Astellas Farma Colombia ... ...
(Date:6/23/2016)... , June 23, 2016  Experian ... integrating and transforming the patient payment and ... several innovative new products and services that ... its revenue cycle offerings. These award-winning solutions ... efficient workflows, remain compliant in an ever-changing ...
Breaking Medicine Technology:
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... 2016 , ... People across the U.S. are sharpening their pencils and honing ... contest in which patients and their families pay tribute to a genetic counselor by ... Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In ...
(Date:6/24/2016)... ... 24, 2016 , ... National recruitment firm Slone Partners is pleased ... and genomics experience, as Vice President of North American Capital Sales at HTG ... leading the sales team in the commercialization of the HTG EdgeSeq system and associated ...
Breaking Medicine News(10 mins):